The LLS recently increased the co-pay assistance amount available for US WM patients to $7,500 to help defray medical costs.
The WhiMSICAL patient registry has a new set of questions that will enable researchers to map quality of life (QoL) data to treatments.
Mark your calendars for June 7-9, 2019, in Philadelphia, PA, as this will be your opportunity to learn from top researchers and clinicians, fellow patients, and caregivers.
On November 15, 2018, the IWMF issued an RFP to 273 of the leading WM researchers in the world. This RFP was developed together with the Leukemia & Lymphoma Society (LLS).
Tom Hoffmann, MD, retired cardiovascular surgeon and current IWMF Board Member, has been elected to serve as the IWMF’s Vice President for Research.
Find out what a specialty pharmacy is, how it differs from a regular pharmacy, what it has to offer, and why you might need one someday.
Videos with embedded slides (now available online) provide up-to-date details about WM treatment and research, including real time updates from the IWWM10 Workshop.
IWMF President Carl Harrington received an inaugural Peter S. Bing Humanitarian Award at IWWM10 (10th International Workshop on WM), at a ceremony held at the United Nations.
Read the results of the 2018 Global Patient Survey, which was coordinated by the IWMF with the Lymphoma Coalition, and was taken by 764 WMers from 37 countries.
David Young read about a new clinical trial, checked its availability and spoke to a principal investigator – all while having coffee one morning last year.